Glyxambi empagliflozin linagliptin fda approval date?

When was Glyxambi (empagliflozin/linagliptin) approved by the FDA?

Glyxambi, the combination of empagliflozin and linagliptin, received FDA approval on June 24, 2015. [1]

What does that approval date refer to?

That date is the FDA’s approval date for Glyxambi as a fixed-dose combination product containing both drugs. [1]

Sources

[1] https://www.drugs.com/history/glyxambi.html